RecruitingNot ApplicableNCT06102382

The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section


Sponsor

Assiut University

Enrollment

100 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To compare two infusion rates of norepinephrine for prophylaxis against post-spinal hypotension during caesarean delivery.


Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Norepinephrine (0.075) and a drug called Norepinephrine (0.1) for people with cesarean section, hypotension, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 19 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNorepinephrine (0.1)

An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.1 µg/kg/min till 5 minutes after delivery of the fetus.

DRUGNorepinephrine (0.075)

An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.075 µg/kg/min till 5 minutes after delivery of the fetus.


Locations(1)

Assiut University Woman Health Hospital

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06102382


Related Trials